tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

HK:1672 Stock Latest News

Ascletis Pharma Reports Positive Interim Results for ASC30 Obesity Treatment
Company AnnouncementsAscletis Pharma Reports Positive Interim Results for ASC30 Obesity Treatment
3d ago
1672
Ascletis Pharma’s EGM Approves Key Share Schemes
PremiumCompany Announcements
Ascletis Pharma’s EGM Approves Key Share Schemes
19d ago
1672
Ascletis Announces Positive Phase Ia Results for ASC30 in Obesity Treatment
PremiumCompany Announcements
Ascletis Announces Positive Phase Ia Results for ASC30 in Obesity Treatment
1M ago
1672
Ascletis Pharma to Discuss New Share Incentive Schemes at Upcoming EGM
PremiumCompany Announcements
Ascletis Pharma to Discuss New Share Incentive Schemes at Upcoming EGM
1M ago
1672
Ascletis Pharma Proposes New Incentive Schemes to Attract Talent
PremiumCompany Announcements
Ascletis Pharma Proposes New Incentive Schemes to Attract Talent
1M ago
1672
Ascletis Pharma Announces EGM Book Closure Period
PremiumCompany AnnouncementsAscletis Pharma Announces EGM Book Closure Period
1M ago
1672
Ascletis Pharma’s ASC47 Shows Promising Weight Loss Results
Premium
Company Announcements
Ascletis Pharma’s ASC47 Shows Promising Weight Loss Results
2M ago
1672
Ascletis Pharma Advances in Phase III Acne Treatment Trial
Premium
Company Announcements
Ascletis Pharma Advances in Phase III Acne Treatment Trial
3M ago
1672
Ascletis Pharma Unveils Promising ASC47 Weight Loss Results
PremiumCompany Announcements
Ascletis Pharma Unveils Promising ASC47 Weight Loss Results
4M ago
1672
Ascletis Pharma Contests US Importation Ban
PremiumCompany Announcements
Ascletis Pharma Contests US Importation Ban
5M ago
1672
Ascletis Pharma’s Partner Gains FDA Breakthrough Status
PremiumCompany Announcements
Ascletis Pharma’s Partner Gains FDA Breakthrough Status
5M ago
1672
Ascletis Pharma Revises Proceeds Allocation Strategy
PremiumCompany Announcements
Ascletis Pharma Revises Proceeds Allocation Strategy
5M ago
1672
Ascletis Pharma Debuts Dual-Method Obesity Drug Trials
PremiumCompany AnnouncementsAscletis Pharma Debuts Dual-Method Obesity Drug Trials
5M ago
1672
Ascletis Pharma Reports Increased Loss and R&D Progress
Premium
Company Announcements
Ascletis Pharma Reports Increased Loss and R&D Progress
6M ago
1672
Ascletis Pharma Forecasts Substantial Mid-Year Loss
Premium
Company Announcements
Ascletis Pharma Forecasts Substantial Mid-Year Loss
7M ago
1672
Ascletis Pharma Schedules Key Financial Meeting
PremiumCompany Announcements
Ascletis Pharma Schedules Key Financial Meeting
7M ago
1672
Ascletis Pharma Announces Share Buyback Plan
PremiumCompany Announcements
Ascletis Pharma Announces Share Buyback Plan
8M ago
1672
Ascletis Pharma’s Drug Shows Positive Trial Results
PremiumCompany Announcements
Ascletis Pharma’s Drug Shows Positive Trial Results
9M ago
1672
Ascletis Pharma Shareholders Show Solid Support
PremiumCompany Announcements
Ascletis Pharma Shareholders Show Solid Support
9M ago
1672

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >